Investigating how synthetic mucins interact with viruses

Synthetic mucins in epithelial models to probe virus-mucin interactions

NIH-funded research University of Utah · NIH-10875605

This study is looking at new lab-made substances that act like natural mucus to help scientists learn how viruses interact with our body's defenses, which could lead to better treatments for infections and cancers.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-10875605 on NIH RePORTER

What this research studies

This research focuses on developing synthetic mucins, which are designed to mimic the natural mucins found in the body. These synthetic mucins will be used in engineered models to study how viruses interact with mucins, which play a crucial role in protecting our cells from infections. By understanding these interactions, researchers aim to uncover new insights into viral behavior and improve strategies for drug delivery and immune responses. Patients may benefit from advancements in treatments for infections and cancers related to epithelial cells.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with conditions related to epithelial cell function, such as certain cancers or chronic infections.

Not a fit: Patients with conditions unrelated to epithelial cells or mucin interactions may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for viral infections and cancer by enhancing our understanding of mucin interactions.

How similar studies have performed: Other research has shown promise in understanding mucin interactions with pathogens, indicating that this approach could yield valuable insights.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.